is glp 1 semaglutide or tirzepatide the same as vs Tirzepatide, medication class, different receptor targets. Here's Compounded GLP-1 - Semaglutide &

Currently available GLP-1 receptor agonists in the UK include: Exenatide (short-acting and extended-release formulations) - licensed for type 2 diabetes Liraglutide (once-daily injection) - licensed for type 2 diabetes (Victoza) and separately for weight management (Saxenda 3mg) Dulaglutide (once-weekly injection) - licensed for type 2 diabetes, including cardiovascular risk reduction in those with established cardiovascular disease or multiple risk factors Semaglutide (once-weekly injection and oral formulation) - licensed for type 2 diabetes (Ozempic, Rybelsus) and separately for weight management (Wegovy 2.4mg) A related but distinct medication is tirzepatide (once-weekly injection), which is a dual GIP/GLP-1 receptor agonist licensed for type 2 diabetes management

Community protocols describe 250-500 mcg subcutaneous daily, near-umbilical for GI-targeted effect, over 4-6 weeks during dose escalation

By targeting both of these incretin hormone receptors simultaneously, Mounjaro offers a unique mechanism of action that distinguishes it from other diabetes treatments

Tracked 2-DAY UK Delivery

Genetic differences can influence appetite regulation, satiety signaling, insulin response, metabolic flexibility, and side effect sensitivity